Healthcare & Pharma | Connected Planning

Precision planning for healthcare's critical decisions.

Healthcare Operating Intelligence

Live Planning Signal

Drug Demand Forecast Accuracy63%

API Supply Continuity Score72%

Clinical Pipeline ROI Visibility54%

Workforce Planning Confidence67%

89%

DRUG SHORTAGES CARRIED OVER FROM PRIOR YEAR

10M

PROJECTED WORKER SHORTAGE BY 2030

30-50%

TRIAL COST OVERRUNS WITHOUT CONNECTED PLANNING

API sourcing concentration risk flagged. Safety stock review recommended.

THE OPERATING ENVIRONMENT

Four forces reshaping healthcare and pharma operations.

Supply chain fragility, regulatory complexity, pipeline uncertainty, and a deepening workforce crisis are demanding planning capabilities that go well beyond what spreadsheets and legacy EPM tools can deliver.

Drug Shortage and Supply Chain Vulnerability

89% of drug shortages recorded in 2024 were carryovers from the prior year — a pattern that points to planning as the lever with the greatest opportunity for improvement. API sourcing is concentrated primarily in India and China, and regulatory demands for supply chain diversification are adding cost and complexity.

Regulatory Compliance Cost

Pharmaceutical enterprises operate under GxP, FDA, CDSCO, and EMA frameworks that impose real planning discipline — connecting that discipline to commercial, financial, and operational planning is where the biggest opportunity lies.

Clinical Pipeline Uncertainty and Competitive Pressure

Drug development programmes carry significant cost and timeline uncertainty, requiring planning models that accommodate probability-weighted pipeline scenarios. At the same time, patent cliffs and aggressive generic pricing are compressing revenue for originator pharma businesses just as R&D investment requirements are rising.

Healthcare Workforce Crisis

A projected global shortage of 10 million healthcare workers by 2030 is creating operational planning demands for hospitals and healthcare systems that have no precedent.

CORE CAPABILITIES

Planning capabilities built for healthcare and pharma.

Four connected capabilities addressing the distinct planning demands of pharmaceutical manufacturing, clinical development, supply chain compliance, and healthcare delivery.

Pharmaceutical Demand and Launch Planning

Our demand models reflect the specific drivers of pharmaceutical demand, including disease epidemiology, treatment protocol trends, tender cycle seasonality, and channel dynamics, and connect pre-launch investment to revenue ramp forecasts by geography and channel.

Clinical Pipeline Financial Modelling

We build probability-weighted pipeline planning models connecting clinical development milestones, success rate assumptions, and regulatory timeline scenarios to financial outcomes.

Pharmaceutical Supply Chain and Regulatory Compliance Planning

We build multi-echelon supply chain planning models integrating API sourcing, manufacturing scheduling, quality hold provisions, and distribution channel requirements, alongside a compliance cost planning model integrating pharmacovigilance obligations, GxP audit requirements, and regulatory submission timelines.

Hospital Capacity and Workforce Planning

We connect patient demand forecasting by speciality, admission type, and seasonal pattern to clinical workforce scheduling and capital capacity planning.

BUSINESS IMPACT

What connected planning delivers for healthcare and pharma.

Drug shortages are often described as supply chain problems. In our experience, they are almost always planning problems. That is where GenXAI helped us most.

— VP, Global Supply Chain, Pharmaceutical Enterprise

PROOF POINTS

Results from real healthcare and pharma engagements.

Representative outcomes from connected planning deployments across pharmaceutical manufacturing, specialty pharma, and healthcare delivery.

PHARMACEUTICAL MANUFACTURING

68% shortage reduction

Anaplan

Pharma Company Reduces Drug Shortage Events by 68%

A mid-size generic pharmaceutical manufacturer experiencing recurring drug shortage events built a connected demand and supply chain planning environment on Anaplan. Drug shortage events fell by 68% in year one.

SPECIALTY PHARMA

3 weeks → 2 days reporting

Pigment

Specialty Pharma Group Builds Risk-Adjusted Pipeline Financial Model

A specialty pharmaceutical company with a 14-asset clinical pipeline built a connected pipeline planning model on Pigment. Board pipeline reporting now takes 2 days rather than 3 weeks.

FAQ

Frequently Asked Questions

Common questions from healthcare and pharma leaders evaluating connected planning.

Pharmaceutical supply chain planning has specific requirements: quality hold and retest provisions, GxP documentation, API sourcing concentration risk, and regulatory-mandated safety stock calculations.

Yes. Probability-weighted pipeline planning with milestone-linked financial commitments is a core capability.

START YOUR JOURNEY

Build a connected planning model for your healthcare or pharma organisation.

Connect demand forecasting, supply chain planning, clinical pipeline modelling, compliance, and workforce through a single intelligence-led planning environment — and make faster, more precise decisions at every level of the organisation.